Use of Telemedicine in the United States (US) during the COVID-19 Pandemic - Coronavirus Disease 2019 (COVID-19) Sector Impact

Use of Telemedicine in the United States (US) during the COVID-19 Pandemic - Coronavirus Disease 2019 (COVID-19) Sector Impact



Prior to the COVID-19 pandemic, telemedicine had not reached its full potential in the US, with several barriers preventing its widespread uptake, including reimbursement and access issues, lack of awareness, resistance to change, preference for in-person care, and technical and connectivity issues.

It is widely anticipated that COVID-19 may be the tipping point for telemedicine as the full potential of the technology is increasingly realized by patients, healthcare systems, and payers. As a result of the pandemic, regulations and policies governing reimbursement and use of telemedicine have changed significantly, leading to expanded access and an unprecedented demand for these services. The report assesses the use of live videoconferencing technologies, which allow the provision of on-demand, virtual, outpatient care during the COVID-19 pandemic as a result of social distancing and lockdown measures.

Scope

- The main scope of this report is the use of live videoconferencing technologies, which allow the provision of on-demand, virtual, outpatient care during the COVID-19 pandemic as a result of social distancing and lockdown measures.
- It assesses the use of telemedicine in the US prior to the COVID-19 pandemic, including the reimbursement environment.
- It also provides an overview of the current landscape, including changes to different regulatory and reimbursement policies that have facilitated widespread expansion of the technology.
- It includes primary research from physician surveys and interviews, and healthcare industry polls.
- The report also provides an evaluation of the main opportunities and challenges currently facing the telemedicine sector in the US.
- It includes a breakdown of the US telemedicine market with a focus on companies that provide standalone patient and physician on-demand telemedicine platforms. This includes analyses of third-party mobile app downloads and website traffic data to demonstrate the surge in demand witnessed during the pandemic.
- Deals in the telemedicine sector since 2019 are also analyzed, including funding, strategic partnerships, and mergers and acquisitions (M&As).
- There are also a number of case studies looking at different competitors and therapy areas such as mental health and inflammatory bowel disease (IBD).

Reasons to Buy

- Develop business strategies by understanding how telemedicine is being used today and how the technology is expected to affect the healthcare sector in the future.
- Stay up to date on the key players in the telemedicine space and where they sit in the value chain.
- See what activities telemedicine players, healthtech companies, payers, and biopharmaceutical companies are undertaking in the space.
- Identify emerging industry trends to gain a competitive advantage.
- Identify opportunities for partnerships with telemedicine companies.

2. Introduction
2.1. What Is Telemedicine?
2.2. Types Of Telemedicine
2.3. Benefits Of Telemedicine
2.4. Barriers To Telemedicine
3. Telemedicine Sector Before COVID-19
3.1. Use Of Telemedicine Had Been Increasing But Was Still Low
3.2. Telemedicine Regulation In The Us Before COVID-19
4. Telemedicine Sector During COVID-19
4.1. Changes To Telemedicine Policies During The COVID-19 Pandemic
4.1.1. Expansion Of Medicare Coverage
4.1.2. Changes To State Legislation
4.1.2.1. Medicaid
4.1.2.2. Commercial Health Plans
4.1.3. Relaxation Of Hipaa Rules
4.1.4. Funding For Healthcare Providers To Improve Telehealth Capabilities
4.2. Increased Demand For Telemedicine During The Pandemic
4.2.1. Hospitals And Healthcare Providers
4.2.2. Payers
4.2.3. Telemedicine Companies
4.3. Access To Telemedicine In The Us After COVID-19
5. What Do Physicians And The Healthcare Industry Think?
5.1. Specialist Primary Research
5.2. Healthcare Industry Polls
6. Opportunities And Challenges For Telemedicine In The Us
6.1. Opportunities
6.1.1. Changes To Certain Telemedicine Regulations Likely To Be Made Permanent
6.1.2. Continued Acceptance Of Digital Health Technologies
6.1.3. Advances In Remote Patient Monitoring And Mhealth
6.1.4. The Growing Aging Population And Chronic Disease Management
6.1.5. Increased Demand For Telemedicine In Mental Health
6.1.6. Addressing Physician Shortages In Primary Care
6.1.7. Supporting Young Adults Without Primary Care Physicians
6.1.8. Reaching Underserved And Uninsured Populations
6.1.9. Increased Funding And Strategic Partnerships In Telemedicine
6.2. Challenges
6.2.1. Raising Patient And Provider Awareness
6.2.2. Loss Of Employer Health Insurance During The COVID-19 Pandemic
6.2.3. Overcoming Privacy And Security Concerns
6.2.4. Technology And Connectivity Requirements
6.2.5. Integration Of Telemedicine Into Existing Healthcare It Systems
7. Market Analysis
8. Appendix

List Of Tables

Table 1: Common Types of Services Provided by Telemedicine Companies
Table 2: Medicaid Telemedicine Coverage in Response to COVID-19
Table 3: Breakdown of State Actions on Telemedicine Coverage by Commercial Payers During the Pandemic
Table 4: Leading Telemedicine Platforms for Patients in the US
Table 5: Mobile App Downloads for Leaders and Challengers in the Telemedicine Platforms for Providers
Table 6: Funding Activity in the Telemedicine Space
Table 7: Strategic Alliances and Partnerships in the Telemedicine Space
Table 8: M&As in the Telemedicine Space

List Of Figures

Figure 1: Telemedicine Is a Subset of Telehealth
Figure 2: Benefits of Telemedicine
Figure 3: Patient and Physician Barriers to Telemedicine Use
Figure 4: Use of Telehealth is Increasing and is Driven by Non-Hospital-Based Provider-to-Patient Interactions
Figure 5: Percentage of Large Employer Plans Covering Telemedicine, 2015-2019
Figure 6: Timeline of Key Regulatory and Policy Changes Related to Telemedicine in the US
Figure 7: State Mandated Expansion of Telehealth Services by Commercial Payers During the COVID-19 Pandemic
Figure 8: US Physicians Use of Telemedicine Before the COVID-19 Pandemic
Figure 9: Change in the Proportion of US Physicians Using Telemedicine During the COVID-19 Pandemic
Figure 10: US Physicians Expected Use of Telemedicine After the COVID-19 Pandemic
Figure 11: Industry Perspective on the Impact of Telemedicine During the COVID-19 Pandemic
Figure 12: Industry Perspective on the Main Benefits of Telemedicine
Figure 13: Industry Perspective on Challenges to the Adoption of Telemedicine During the COVID-19 Pandemic
Figure 14: Industry Perspective on Areas Most Suitable for Continued Telemedicine Adoption
Figure 15: Ways to Address Clinical Trial Disruptions Related to the COVID-19 Pandemic
Figure 16: Types of On-Demand Urgent Care Telemedicine Providers
Figure 17: Leaders and Challengers in the On-Demand Urgent Care Telemedicine Space
Figure 18: Global Mobile App Downloads Across Key Telemedicine Players, July 2019-June 2020
Figure 19: Website Traffic for Leading Telemedicine Platforms for Patients, July 2019-June 2020
Figure 20: Website Traffic for Challenger Companies with Telemedicine Platforms for Patients, July 2019-June 2020
Figure 21: Website Traffic for Leading Telemedicine Software/Platforms for Providers, July 2019-June 2020
Figure 22: Website Traffic for Challenger Telemedicine Software/Platforms for Providers, July 2019-June 2020
Figure 23: Telemedicine Funding by Quarter, Q1 2019-Q2 2020
Figure 24: Established Telemedicine Partnerships, Q1 2019-Q2 2020
Figure 25: Telemedicine Provider Partnerships by Type
Figure 26: The Teladoc Mobile Application for Patients
Figure 27: Amwell: Doctor Visits 24/7 Mobile Application for Consumers
Figure 28: The HeyDoctor by GoodRx Mobile Application for Patients
Figure 29: The Doxy.me Platform for Physicians
Figure 30: Thera-LINK Appointment Scheduler on the Physician Platform
Figure 31: US Telemedicine Usage in IBD
Figure 32: Trending Keywords from Digital Pharma Influencers in March 2020
Figure 33: Tweets Related to Telemedicine from Top Digital Pharma Influencers in March 2020

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available